Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Samuel

Showing results (31-40 of 712) with videos related to

Pageof 72
Sort By:
Molecular Cell|June 22, 2019
The Devil Is in the Microbial Genetic DetailsAdrien Assié, Buck S Samuel
The Journal of Trauma|February 20, 2007
Giant arteriovenous fistula of the upper extremity after distal radius fracture: a rare complication after a common problemS Samuel Bederman, Dimitri J Anastakis
Current Molecular Medicine|January 17, 2022
Immune Mechanisms and Related Targets for the Treatment of Fibrosis in Various OrgansAnita A Pinar, Chrishan S Samuel
Biochemical Pharmacology|December 30, 2021
Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directionsChrishan S Samuel, Robert G Bennett
The Nurse Practitioner|December 19, 2015
Identifying early signs of peripheral neuropathy among patients with diabetes mellitusBernice S Samuel, Susan J Appel
Journal of Assisted Reproduction and Genetics|May 23, 2012
Fertility preservation in young women with breast cancerJennifer R Klemp, S Samuel Kim,
Biochemical Society Transactions|December 19, 2018
Rho-ROCK signaling regulates tumor-microenvironment interactionsMohammad Zahied Johan, Michael S Samuel
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2019
Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathwayS Samuel Weigt, Laurie D Snyder
Kidney International|May 5, 2006
Relaxin in cardiovascular and renal diseaseC S Samuel, T D Hewitson
The American Journal of Bioethics : AJOB|June 14, 2016
Is It Practical to Apply Moral Hazard in the Pediatric Setting?Jessica Anne Moore, Sanju S Samuel
Pageof 72

Showing results (31-40 of 712) with videos related to

Sort By:
Pageof 72
Molecular Cell|June 22, 2019
The Devil Is in the Microbial Genetic DetailsAdrien Assié, Buck S Samuel
The Journal of Trauma|February 20, 2007
Giant arteriovenous fistula of the upper extremity after distal radius fracture: a rare complication after a common problemS Samuel Bederman, Dimitri J Anastakis
Current Molecular Medicine|January 17, 2022
Immune Mechanisms and Related Targets for the Treatment of Fibrosis in Various OrgansAnita A Pinar, Chrishan S Samuel
Biochemical Pharmacology|December 30, 2021
Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directionsChrishan S Samuel, Robert G Bennett
The Nurse Practitioner|December 19, 2015
Identifying early signs of peripheral neuropathy among patients with diabetes mellitusBernice S Samuel, Susan J Appel
Journal of Assisted Reproduction and Genetics|May 23, 2012
Fertility preservation in young women with breast cancerJennifer R Klemp, S Samuel Kim,
Biochemical Society Transactions|December 19, 2018
Rho-ROCK signaling regulates tumor-microenvironment interactionsMohammad Zahied Johan, Michael S Samuel
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2019
Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathwayS Samuel Weigt, Laurie D Snyder
Kidney International|May 5, 2006
Relaxin in cardiovascular and renal diseaseC S Samuel, T D Hewitson
The American Journal of Bioethics : AJOB|June 14, 2016
Is It Practical to Apply Moral Hazard in the Pediatric Setting?Jessica Anne Moore, Sanju S Samuel
Pageof 72